Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-149,086
Closed -$4.46M 541
2025
Q3
$4.46M Sell
149,086
-7,088
-5% -$237K 0.11% 197
2025
Q2
$4.64M Sell
156,174
-49,782
-24% -$1.43M 0.11% 172
2025
Q1
$6.29M Hold
205,956
0.15% 148
2024
Q4
$8.16M Buy
205,956
+74,275
+56% +$2.89M 0.18% 140
2024
Q3
$5.11M Buy
131,681
+8,698
+7% +$352K 0.11% 182
2024
Q2
$5.17M Buy
+122,983
New +$4.2M 0.13% 157

Other funds holding SRDX

AQR Arbitrage's SRDX Position: Q4 2025 in Review

AQR Arbitrage sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 149,086 shares — an estimated $4.46M sold.

AQR Arbitrage first reported a position in SRDX in Q2 2024 and held it in 6 quarters. The position peaked at $8.16M in Q4 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • AQR Arbitrage reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • AQR Arbitrage sold 149,086 Surmodics shares in Q4 2025, an estimated $4.46M.
  • AQR Arbitrage first reported a position in Surmodics in Q2 2024 and held it in 6 quarters.
  • AQR Arbitrage's Surmodics position peaked at $8.16M in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on AQR Arbitrage's 13F filing for Q4 2025, filed 17 Feb 2026.